Skip to main content
High RiskFDAfda-Z-0291-2021OTHER

GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System

Units Affected
19,013
Recall Date
September 9, 2020
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-Z-0291-2021.

When the delivery catheter was attempted to be removed, there was an observed connection between the stent graft and the delivery catheter that prevented the delivery catheter from being withdrawn.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-Z-0291-2021.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact W L Gore & Associates, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-Z-0291-2021.

W L Gore & Associates, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

W L Gore & Associates, Inc. Recall FAQ

W L Gore & Associates, Inc. is the subject of a medical implants safety report: GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The notice was published on September 9, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 19,013 units are potentially affected.